Galactosemia (GAL), due to Gal-1-PO 4 uridyltransferase deficiency, is an inborn error of galactose metabolism causing neonatal morbidity and mortality. The general ...

"Newborn screening for Galactosemia is mandatory in the U.S. and most E.U. countries," the company said. Founder and Chief Executive Officer (CEO) Shoshana Shendelman expressed disappointment in ...

[4–10] In the newborn, the clinical presentation depends ... condition unveiled by the introduction of feeding (i.e., galactosemia, hereditary fructose intolerance or hereditary tyrosinemia ...